Home / Business and Economy / Agilisium Moves HQ to Hyderabad, Eyes Growth
Agilisium Moves HQ to Hyderabad, Eyes Growth
27 Oct
Summary
- Agilisium is relocating its Asia headquarters from Chennai to Hyderabad.
- The move aims to leverage Hyderabad's strong pharmaceutical and biotech ecosystem.
- The company targets $500 million revenue and 5,000 professionals within seven years.
Agilisium, a company focused on innovation and transformation in the Life Sciences sector, is relocating its Asia headquarters from Chennai to Hyderabad.
This strategic shift is driven by the desire to tap into Hyderabad's robust pharmaceutical and biotechnology ecosystem. The city provides access to specialized talent in Life Sciences, technology, and artificial intelligence, which are crucial for the company's growth.
Telangana's increasing emphasis on Life Sciences innovation, bolstered by dedicated leadership and the BioAsia platform, further enhances Hyderabad's appeal for Agilisium. This relocation is expected to strengthen the company's innovation capabilities and facilitate the development of specialized solutions for global Life Sciences clients.
The move aligns with Agilisium's long-term objectives of achieving $500 million in revenue and expanding its workforce to around 5,000 professionals over the next five to seven years. Chennai and Pune will continue to be integral parts of its core operating footprint.
